CLOSE X

ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE5614.00-21.6 (-0.38 %)
PREV CLOSE ( ) 5635.60
OPEN PRICE ( ) 5635.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 102305
TODAY'S LOW / HIGH ( )5599.00 5699.90
52 WK LOW / HIGH ( )4740.65 5933
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 08-08 1973
Management Info
Basudeo N Singh - Chairman Sandeep Singh - Managing Director
Registered Office

Address Alkem House,Senapati Bapat Marg,Lower Parel (West),
Mumbai,
Maharashtra-400013

Phone 022 3982 9999

Email investors@alkem.com / contact@alkem.com

Website www.alkemlabs.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
16Jul Alkem Laboratories informs about acqui
Alkem Laboratories has informed that the Company has acquired 79,36,50,7..
02Jul Alkem Laboratories informs about news
Pursuant to Regulation 30 and 47 read alongwith Schedule III of the SEBI..
29Jun Alkem Laboratories informs about upda
In continuation of its earlier intimations dated 13th February, 2026 and..
10Jun Alkem Laboratories submit analyst meet
With reference to relevant provisions of the SEBI (Listing Obligations a..
03Jun Alkem Laboratories launches semaglutid
Alkem Laboratories has launched semaglutide in single-shot pre-filled sy..
Financials
Rs. in Millions
QTR Mar 26 ANNUAL 26
Net Profit2170.622820.9
Gross Profit 3360.9 25226.2
Operating Profit 5497.129795.6
Net Sales 22584.496639.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 18975.40 (2.18%)
M.Cap ( in Cr)24345.23
Divi's Laboratories (BSE)
 7416.35 (2.34%)
M.Cap ( in Cr)196880.79
Astrazeneca Pharma (BSE)
 8167.90 (2.10%)
M.Cap ( in Cr)20419.75
Hester Biosciences (BSE)
 2528.50 (6.94%)
M.Cap ( in Cr)2150.96
Caplin Point Labs. (BSE)
 2623.15 (6.43%)
M.Cap ( in Cr)19939.01
Shareholding Pattern
PROMOTERS 49.7%
NON-INSTITUTION 17.25%
MUTUAL FUNDS/UTI 16.71%
FI/BANKS/INSURANCE 4.17%
GOVERNMENT 0%
FII 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

Advisory for Investors Complaints Data June 2026 Broking Complaints Data June 2026 DP

Filing of complaints through SEBI’s online portal ‘SCORES’ and ‘SMARTODR portal’ - Easy & quick

  • > Register On SCORES / SMARTODR Portal
  • > Mandatory Details For filling Complaints on SCORES: (Name, PAN, Address, Mobile Number, Email ID)
  • > Benefits:
    • Effective communication
    • Speedy Redressal of Grievance / Dispute
  • http://scores.sebi.gov.in
  • https://smartodr.in/login
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.